Introduction
Background
Winchester syndrome (WS) is a syndrome of pathologic changes consisting of dwarfism (resulting from disturbances of the skeletal-articular system), corneal opacities, coarsening of facial features, leathery skin, and hypertrichosis.
In 1969, Winchester et al first described pathologic changes in 2 sisters aged 3.5 and 12 years, the offspring of first cousins. These sisters were reported to have "a new acid mucopolysaccharidosis" with skeletal deformities that simulated rheumatoid arthritis.1 Later, Brown and Kuwabara2 performed corneal biopsy in the younger sibling, whose case is discussed in the report by Winchester et al1 ; the results were characteristic of the mucopolysaccharidoses.
In 1974, Hollister et al reported 3 cases of this disease in consanguineous relatives from Mexico: 2 sisters aged 8 and 9.5 years and their 22-year-old cousin.3,4 The authors first called the constellation of findings Winchester syndrome. In particular, they noted skin changes in the trunk and extremities that Winchester et al did not report.1 In 1977, Nabai described a sixth patient, a 3-month-old boy from Iran.5 In 1978, Irani et al reported a similar case in a 4-year-old boy from Bombay.6 In both cases, the parents were first cousins.
In 1987, Dunger et al reported 2 additional cases.7 The first patient had features similar to those of infantile systemic hyalinosis; Winter also emphasized these features.8 The other patient was a 16-year-old male adolescent. Lambert et al presented a subsequent report on 2 cases in siblings, a girl aged 13 months and a girl aged 12 years, in France.9 The most recent case of Winchester syndrome was in a 40-year-old woman from the United States; this woman had additional dental disorders with inflammation of the gums. The data in patients with Winchester syndrome are presented in the Table below.
Clinical Features of Patients with Winchester syndrome*Open table in new window
Table
| Clinical Feature | Winchester et al, 1969 1 | Hollister et al, 1974 3, 4 | Nabai et al, 1977 5 | Irani et al, 1978 6 | Dunger et al, 1987 7 | Prapanpoch et al, 1992 10 | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Case 1 | Case 2 | Case 1 | Case 2 | Case 3 | Case 1 | Case 1 | Case 1 | Case 2† | Case 1 | |
| Sex | F | F | F | F | M | M | M | F | F | F |
| Age | 12 y | 3.5 y | 9.5 y | 8 y | 22 y | 3 mo | 4 y | 2 | 16 y | 40 y |
| Onset | 2 mo | 1 y | 1 y | 1 mo | 1 y | 1 mo | 1 y | 1 mo | 1 y | ND |
| Consanguinity | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | ND |
| Skin changes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Coarse face | Yes | Yes | No | No | Yes | Other‡ | No | Yes | Yes | Yes |
| Thickened facial skin | No | No | Yes | Yes | Yes | Yes | No | Yes | No | Yes |
| Hyperpigmented patches | No | No | Yes | Yes | Yes | Yes | Yes | No | No | No |
| Skin nodules | No | No | Yes | No | No | No | No | Yes | No | No |
| Corneal opacity | Yes | Yes | Yes | Yes | Yes | No | No | No | No | Yes§ |
| Gum hypertrophy | Yes | Yes | Yes | Yes | ND | Yes | No | Yes | Yes | No |
| Short stature | Yes | Yes | Yes | Yes | Yes | No | ND | Yes | Yes | Yes |
| Flexion contractures | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Osteoporosis (visible on radiographs) | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Osteolysis of the carpal and tarsal bones | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes |
| Abnormal test results|| | No | No | No | IgM | IgM | IgM¶ | No | Yes# | Yes# | No |
| Patient location | USA | USA | Mexico | Mexico | Mexico | Iran | India | Iran** | India** | USA |
| Clinical Feature | Winchester et al, 1969 1 | Hollister et al, 1974 3, 4 | Nabai et al, 1977 5 | Irani et al, 1978 6 | Dunger et al, 1987 7 | Prapanpoch et al, 1992 10 | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Case 1 | Case 2 | Case 1 | Case 2 | Case 3 | Case 1 | Case 1 | Case 1 | Case 2† | Case 1 | |
| Sex | F | F | F | F | M | M | M | F | F | F |
| Age | 12 y | 3.5 y | 9.5 y | 8 y | 22 y | 3 mo | 4 y | 2 | 16 y | 40 y |
| Onset | 2 mo | 1 y | 1 y | 1 mo | 1 y | 1 mo | 1 y | 1 mo | 1 y | ND |
| Consanguinity | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | ND |
| Skin changes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Coarse face | Yes | Yes | No | No | Yes | Other‡ | No | Yes | Yes | Yes |
| Thickened facial skin | No | No | Yes | Yes | Yes | Yes | No | Yes | No | Yes |
| Hyperpigmented patches | No | No | Yes | Yes | Yes | Yes | Yes | No | No | No |
| Skin nodules | No | No | Yes | No | No | No | No | Yes | No | No |
| Corneal opacity | Yes | Yes | Yes | Yes | Yes | No | No | No | No | Yes§ |
| Gum hypertrophy | Yes | Yes | Yes | Yes | ND | Yes | No | Yes | Yes | No |
| Short stature | Yes | Yes | Yes | Yes | Yes | No | ND | Yes | Yes | Yes |
| Flexion contractures | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Osteoporosis (visible on radiographs) | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Osteolysis of the carpal and tarsal bones | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes |
| Abnormal test results|| | No | No | No | IgM | IgM | IgM¶ | No | Yes# | Yes# | No |
| Patient location | USA | USA | Mexico | Mexico | Mexico | Iran | India | Iran** | India** | USA |
† Additional clinical details obtained at repeat examination by Winter.
‡ Upper lip was hypertrophic.
§ Glaucoma was present.
|| Increased immunoglobulin M (IgM) levels were observed.
¶ Increased para-amino-isobutyric acid, leucine, and proline levels in the urine.
# Abnormal oligosaccharide in the urine.
** Cases reported in Great Britain.
Pathophysiology
Winchester syndrome appears to be inherited in an autosomal recessive manner.1,11 The specific cause of the changes has not been clarified. The changes that occur in this syndrome are presumed to be a consequence of metabolic disturbances of glycosaminoglycans, and the syndrome is believed to be a mucopolysaccharidosis with unknown enzymatic disturbances.1,10,11 Dunger et al found an abnormal oligosaccharide consisting of a molecule of fucose and 2 molecules of galactose in the urine of 2 patients with Winchester syndrome.7
Studies performed by Hollister et al3 and Cohen et al11 did not reveal morphologic evidence of lysosomal storage. These authors believe that metachromasia of the fibroblasts and a 2-fold increase in the uronic acid content in these fibroblasts1 are not sufficient evidence for diagnosing mucopolysaccharidosis because uronic acid is also observed in as many as 27% of healthy people.
In patients with established diagnosis of a disease that has features of mucopolysaccharidosis, the uronic acid level is 5-10 times greater than that of the control group.3,11 The authors believe that Winchester syndrome is a disease that should be classified as a nonlysosomal connective-tissue disturbance and not as a form of acid mucopolysaccharidosis. Their results suggest that fibroblasts play a major role in this syndrome of pathologic changes. Corneal opacities; leathery skin; abnormal collagen in the dermis; and, possibly, contractures are likely manifestations of anomalous fibroblast functions. The authors recommend further studies to determine the pathogenesis of this autosomal recessive disorder.
A homozygous missense mutation (E404K) in the active site of matrix metalloproteinase 2 was found in a 21-year-old woman with a severe form of osteolysis best compatible with a diagnosis of Winchester syndrome.12 A novel homozygous MMP2 mutation was identified in a family with Winchester syndrome.13 Torg syndrome, nodulosis-arthropathy-osteolysis, and Winchester syndrome may be allelic disorders.14
Frequency
United States
In the United States, 3 cases were described.
International
Cases in 3 Mexican patients are described (published in the United States). Two cases are described in France; 1 case, in India; 1 case, in Iran; and 2 cases, in Great Britain. The 2 cases in Great Britain involved patients from Iran (case 1) or India (case 2).7 See the Table in Background.
In a 32-year period from 1969-2001, 12 cases of Winchester syndrome are described worldwide.
Race
No racial predisposition is recognized.
Sex
- Winchester syndrome appears to be more common in women than in men, with a female-to-male ratio of 3:1 (9 women, 3 men).
- The data presented in the Table in Background do not include 2 cases described by Lambert et al.9
Age
The initial changes in the bony-articular system may be observed in infants usually when they are aged about 1 year.
- In 4 patients, the initial changes occurred earlier. In 3 patients, changes occurred when they were aged 1 month, the fourth patient was aged 2 months when the changes occurred.
- Winchester syndrome was usually diagnosed in the described cases when the patients were aged 3.5-16 years.
- In 1 case, the syndrome was recognized in an infant aged 3 months,5 and in the other 2 cases, the patients were aged 22 and 40 years (see the Table in Background).
Clinical
History
This rare genetic syndrome is one of the inherited osteolysis disorders characterized by destruction and resorption of affected bones with consequent skeletal deformities and functional impairment.15 Dissolution of carpal and tarsal bones with generalized osteoporosis, progressive joint contractures, short stature, peripheral corneal opacities, and coarse facial features are often seen, although the clinical features vary. Cutaneous features may include diffusely thickened and leathery skin; hypertrichosis; patches of hyperpigmented, hypertrichotic leathery skin in an annular or linear distribution; subcutaneous nodules; gingival hypertrophy; and widespread progressive multilayered symmetrical restrictive banding of the skin.
- Perinatal period
- The gestation and delivery of children with later features of Winchester syndrome are normal.
- In the first case, as described by Winchester et al, closure of the frontal fontanel was delayed until the patient was aged 3 years; in the second case, eruption of the milk teeth was delayed until the patient was aged 12 months.1
- Pathologic changes
- The onset of pathologic changes occurred during the patient's first 2 months of life, as Winchester et al,1 Hollister et al,3,4 and Nabai et al5 described.
- The first pathologic changes usually occurred during the patient's first year of life.1,4,6
- In the first stage of the disease, inflammatory conditions appeared with painful joints and limited mobility, which suggests rheumatoid arthritis. These inflammatory changes usually involved the small joints, such as the interphalangeal, metacarpophalangeal, and carpal joints.
- The changes occurred bilaterally and symmetrically.1,3,4,5,6,10
- At the same time, changes may develop in the large joints, such as the knee and vertebral joints.1
- In the second case, Winchester described findings in a 3.5-year-old girl who had changes in the joints that caused stiffness of the vertebral column and extremities. This stiffness was present before the patient was aged 20 months.
- The progressive course of the disease may last for many years and lead to permanent flexion contractures in the small joints of the hands and feet, as well as in the knee, hip, elbow, and shoulder joints. Similar changes may be observed in the vertebral column. Inflammatory changes in the joints may result in a failure to thrive.
- Peripheral corneal opacities occurred when patients were aged 2-5 years, or the opacities were found later.1 In later years, the children had poor eyesight. In 5 reported cases in children aged 3 months, 13 months, 4 years, 12 years, and 16 years, cataracts were not found.5,6,7,9
- Craniofacial deformities
- Deformities and coarsening of the facial features is found at different stages of the disease.
- In patients described by Winchester et al,1 craniofacial deformities were visible when the patient was aged 20 months in the first case and at 8 years in the second case.
- In the third case described by Hollister et al,3,4 intense coarsening of the facial features was observed when the patient was aged 22 years.
- Other abnormalities
- Abnormalities also occur on the limbs and trunk. These abnormalities present different morphologic pictures.
- These abnormalities were not found in the 2 patients described by Winchester et al.1
- In other cases, thickening and hyperpigmentation of the skin occurred in the initial period of the disease or later.5
Physical
In diagnosing Winchester syndrome, the following examination results and characteristic symptoms of the pathologic changes should be taken into account:
- Case history with familial occurrence in siblings and cousins with a recessive autosomal inheritance pattern
- Articular changes that occur when the patient is aged about 1 year, combined with complaints similar to those of rheumatoid arthritis
- In older patients, permanent damages and deformities of the joints and short stature
- Characteristic radiologic changes of the skeleton with features of multifocal osteoporosis, including a real lack of the carpal and tarsal bones
- Peripheral corneal opacities
- Coarsening of facial features
- Gum hypertrophy
- Focal or diffuse thickenings, with leathery skin, hyperpigmentation, and hypertrichosis
- Characteristic histopathologic picture of skin lesions
In 1989, Winter8 proposed diagnostic criteria for Winchester syndrome. These include the described skeletal radiologic characteristics (see Imaging Studies) combined with at least 2 of the following features: short stature and progressive articular contractures, corneal opacities, thickened hyperpigmentations or hirsutism of the skin, hypertrophy of the gums, and coarsened facial features.
Clinical changes in Winchester syndrome are multisystemic. They can be found in many tissues and organs.
- Bony-articular system
- Pathologic changes occur in small joints and large joints, as well as in the vertebral column.
- Involvement of these joints and the vertebral column is the basic feature of this pathologic syndrome.
- Deformities may occur as a consequence of changes in the bones that form the joints and edema of the periarticular tissues.
- These changes can be found in the joints of the hands and the digits of the feet, as well as in the wrists and metatarsi. Similar changes can occur in the knee, elbow, shoulder, and hip joints, and they can also involve the backbone.
(A) Case 1. Girl aged 2.5 years. Destruction of the carpal ossification centers that have appeared early is visible. (B) Case 1. Girl aged 6 years. The carpals are totally destroyed, and erosion of the proximal metacarpals is seen. The phalanges are expanded and appear cystic. Destructive arthritis is observed in the metacarpal, phalangeal, and interphalangeal joints. (C) Case 1. Girl aged 12 years. Only small portions of the metacarpals remain, and destruction of the phalanges of the fifth finger has occurred. The distal radius and ulna are flared. Courtesy of Patricia Winchester, MD, Departments of Radiology, Pediatrics, and Medicine, Cornell University Medical College and the New York Hospital, Cornell Medical Center, 525 East 68th Street, New York, NY 10021.
- Spontaneous pain occurs in these joints. This pain is aggravated by movements and palpation at examination.
- Flexion contractures occur in these joints.
- The hands are deformed as a consequence of osteoporosis and osteolysis of the wrist bones, metacarpals, and phalanxes of the hands.
- Shortening of the wrist metacarpals in the flexion position may be visible, with claw positioning of the fingers.
- In patients with chronic disease, shortening of the fingers with a deformation may occur as a consequence of total resorption of the phalangeal bones of the fingers.
- In the foot region, osteoporosis of the metatarsals and the phalanges can be observed with osteolysis of the tarsal bones. Deformations of the feet with shortening of the tarsus and metatarsus,1,4,5,11 sometimes with features of equine foot,10 are observed.
- Short stature (below the third percentile) is a characteristic feature of patients with Winchester syndrome.
- Short stature is presumably a consequence of osteolytic and degenerative changes of the vertebral bodies of the backbone and the long bones of the limbs.
- The long bones may show osteolytic destruction with rarefaction and atrophy of the spongy and cortical bone tissue, sometimes with thinning of the cortical part to 1 mm.9
Case 1. Girl aged 12 years. The knees are ankylosed. The ends of the long bones are flared. The bone density is markedly diminished. The left distal fibula is eroded. Destruction of the small bones of the foot is seen. Courtesy of Patricia Winchester, MD, Departments of Radiology, Pediatrics, and Medicine, Cornell University Medical College and the New York Hospital, Cornell Medical Center, 525 East 68th Street, New York, NY 10021.
- Skin
- Changes in the facial skin and the skin of the trunk and limbs are often characteristic of this syndrome.
- Facial features may be coarsened and deformed.
- The following characteristics may be found: protruding forehead, big fleshy nose with lowering of its dorsum, and thick lips.
- The skin may be thickened and brownish, and sometimes, it may have a leathery consistency.5,6,11
- On the trunk and extremities, the skin may be thickened with associated hyperpigmentation and, sometimes, associated hirsutism.
- Changes in the skin may be focal, oval shape, and 8-12 cm in diameter. The changes can be localized on the back in the scapular region, and smaller ones are symmetrically scattered in the medial and lower parts of the back, as well as on the lateral surfaces of the chest and arms.3,4
- In some patients, changes may be diffuse and occupy a larger surface area on the skin.
- In the case of the 3-month-old infant described by Nabai et al, a diffuse symmetrical skin thickening occurred on the abdomen and both limbs.5 The skin over the metacarpal joints of the phalanxes and phalanxes was thickened with brown hyperpigmentation.
- Eyes
- Corneal opacities, which are also characteristic of this syndrome, are usually localized on the corneal peripheries.
- Corneal opacities may involve the Descemet membrane. Involvement of the Descemet membrane was found in 1 patient.4
- In a 40-year-old woman, the corneal opacities were accompanied by glaucoma.10
- Corneal damage depends on the duration of the disease and worsens as the patient ages.
- Oral cavity: Hypertrophy of the gums is found in most patients.
- Internal organs
Causes
- Winchester syndrome is an inherited familial disorder transmitted in an autosomal recessive manner.
- Isolated cases without familial occurrence are described.
- The molecular causes of the pathologic changes are unknown. Hollister et al4 and Cohen et al11 emphasize the abnormal function of the fibroblasts, which causes some of the pathologic changes in this syndrome.
More on Winchester Syndrome |
Overview: Winchester Syndrome |
| Differential Diagnoses & Workup: Winchester Syndrome |
| Treatment & Medication: Winchester Syndrome |
| Follow-up: Winchester Syndrome |
| Multimedia: Winchester Syndrome |
| References |
| Next Page » |
References
Winchester P, Grossman H, Lim WN, Danes BS. A new acid mucopolysaccharidosis with skeletal deformities simulating rheumatoid arthritis. Am J Roentgenol Radium Ther Nucl Med. May 1969;106(1):121-8. [Medline].
Brown SI, Kuwabara T. Peripheral corneal opacification and skeletal deformities. A newly recognized acid mucopolysaccharidosis simulating rheumatoid arthritis. Arch Ophthalmol. Jun 1970;83(6):667-77. [Medline].
Hollister DW, Rimoin DL, Lachman RS, Cohen AH, Reed WB, Westin GW. The Winchester syndrome: a nonlysosomal connective tissue disease. J Pediatr. May 1974;84(5):701-9. [Medline].
Hollister DW, Rimoin DL, Lachman RS, Westin GW, Cohen AH. The Winchester syndrome: clinical, radiographic and pathologic studies. Birth Defects Orig Artic Ser. 1974;10(10):89-100. [Medline].
Nabai H, Mehregan AH, Mortezai A, Alipour P, Karimi FZ. Winchester syndrome: report of a case from Iran. J Cutan Pathol. Oct 1977;4(5):281-5. [Medline].
Irani A, Shah BN, Merchant RH. The Winchester syndrome: (a case report). Indian Pediatr. Oct 1978;15(10):861-3. [Medline].
Dunger DB, Dicks-Mireaux C, O'Driscoll P, et al. Two cases of Winchester syndrome: with increased urinary oligosaccharide excretion. Eur J Pediatr. Nov 1987;146(6):615-9. [Medline].
Winter RM. Winchester's syndrome. J Med Genet. Dec 1989;26(12):772-5. [Medline].
Lambert JC, Jaffray JY, Michalski JC, Ortonne JP, Paquis V, Saunieres AM. [Biochemical and ultrastructural study of two familial cases of Winchester syndrome]. J Genet Hum. Sep 1989;37(3):231-6. [Medline].
Prapanpoch S, Jorgenson RJ, Langlais RP, Nummikoski PV. Winchester syndrome. A case report and literature review. Oral Surg Oral Med Oral Pathol. Nov 1992;74(5):671-7. [Medline].
Cohen AH, Hollister DW, Reed WB. The skin in the Winchester syndrome. Arch Dermatol. Feb 1975;111(2):230-6. [Medline].
Zankl A, Bonafe L, Calcaterra V, Di Rocco M, Superti-Furga A. Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2. Clin Genet. Mar 2005;67(3):261-6. [Medline].
Rouzier C, Vanatka R, Bannwarth S, et al. A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clin Genet. Mar 2006;69(3):271-6. [Medline].
Zankl A, Pachman L, Poznanski A, et al. Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome. J Bone Miner Res. Feb 2007;22(2):329-33. [Medline].
Sidwell RU, Brueton LA, Grabczynska SA, Francis N, Staughton RC. Progressive multilayered banded skin in Winchester syndrome. J Am Acad Dermatol. Feb 2004;50(2 Suppl):S53-6. [Medline].
Hemingway AP, Leung A, Lavender JP. Familial vanishing limbs: four generations of idiopathic multicentric osteolysis. Clin Radiol. Sep 1983;34(5):585-8. [Medline].
Pai GS, Macpherson RI. Idiopathic multicentric osteolysis: report of two new cases and a review of the literature. Am J Med Genet. Apr 1988;29(4):929-36. [Medline].
Tyler T, Rosenbaum HD. Idiopathic multicentric osteolysis. AJR Am J Roentgenol. Jan 1976;126(1):23-31. [Medline].
Kozlowski K, Barylak A, Eftekhari F, Pasyk K, Wislocka E. Acroosteolysis. Problems of diagnosis--report of four cases. Pediatr Radiol. Apr 19 1979;8(2):79-86. [Medline].
Lemaitre L, Remy J, Smith M, et al. Carpal and tarsal osteolysis. Pediatr Radiol. 1983;13(4):219-26. [Medline].
Fayad MN, Yacoub A, Salman S, Khudr A, Der Kaloustian VM. Juvenile hyaline fibromatosis: two new patients and review of the literature. Am J Med Genet. Jan 1987;26(1):123-31. [Medline].
Landing BH, Nadorra R. Infantile systemic hyalinosis: report of four cases of a disease, fatal in infancy, apparently different from juvenile systemic hyalinosis. Pediatr Pathol. 1986;6(1):55-79. [Medline].
Nezelof C, Letourneux-Toromanoff B, Griscelli C, Girot R, Saudubray JM, Mozziconacci P. [Painful disseminated fibromatosis (systemic hyalinosis): a new hereditary collagen dysplasia]. Arch Fr Pediatr. Dec 1978;35(10):1063-74. [Medline].
Grover S, Grewal RS, Verma R, Mani NS, Mehta A, Sinha P. Winchester syndrome: a case report. Int J Dermatol. Feb 2009;48(2):175-7. [Medline].
Phadke SR, Ramirez M, Difeo A, Martignetti JA, Girisha KM. Torg-Winchester syndrome: lack of efficacy of pamidronate therapy. Clin Dysmorphol. Apr 2007;16(2):95-100. [Medline].
Ball GV, Koopman WJ. Rheumatoid arthritis. In: Kelley WN, DeVita VT, DuPont HL, Harris ED, JR, et al, eds. Textbook of Internal Medicine. Philadelphia, Pa: Lippincott-Raven; 1989:974-81.
Myers LK, Pinals RS. Arthritis in childhood. In: Summit RL, ed. Comprehensive Pediatrics. Toronto, Canada: Mosby; 1990:526-33.
Further Reading
Keywords
WS, Winchester's syndrome, mucopolysaccharidosis, dwarfism, bony-articular changes, corneal opacities, coarsened facial features, leathery skin, hypertrichosis




Overview: Winchester Syndrome